As the Trump administration cuts federal funding for mRNA vaccine research, two top scientific efforts in New York are poised to continue forging mRNA-related breakthroughs aimed at fighting diseases and improving human health.

In Rochester, the Center for RNA Biology, which is affiliated with University of Rochester Medical Center, has national experts working on projects that are seeking to improve understanding of mRNA's role in human health and medicine.

In Westchester County, Regeneron, a top bio-tech company, has workers focused on mRNA research projects, including one aimed at "unlocking the next generation of cancer fighting treatments," according to the company's website .

In statements to the USA TODAY Network, both the University of Rochester Medical Center, or URMC, and Re

See Full Page